Trials / Completed
CompletedNCT06783621
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products
US HARMONY in DIVERSITY: A Prospective, Open-label Study to Evaluate Subject Satisfaction With the Overall Face and Neck Appearance After Combined Treatment
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 22 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A study to evaluate overall participant satisfaction of face and neck appearance after treatment with onabotulinumtoxinA, JUVÉDERM® products, KYBELLA, CoolSculpting Elite, and select SkinMedica products in a diverse population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OnabotulinumtoxinA | Intramuscular Injections |
| DEVICE | JUVÉDERM | Injections |
| DEVICE | CoolSculpting Elite System | CoolSculpting Elite Applicator |
| OTHER | SkinMedica Products | Skincare Product |
| DRUG | KYBELLA | Injections |
Timeline
- Start date
- 2025-01-16
- Primary completion
- 2026-02-26
- Completion
- 2026-02-26
- First posted
- 2025-01-20
- Last updated
- 2026-03-27
Locations
10 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06783621. Inclusion in this directory is not an endorsement.